NEU 0.00% $13.56 neuren pharmaceuticals limited

Ann: Comment on research report, page-151

  1. 2,031 Posts.
    lightbulb Created with Sketch. 478
    It's pretty clear which company was the real target of the Report. The respective share price responses tell that story. Currently, Neuren with a vastly minor interest in Daybue, the relevant content of the Report, compared to Acadia's stake, sits at a hefty share price disadvantage. Makes no sense. Oh wait, Neuren is in discussions, Neuren has NNZ 2591, Neuren's shares are tightly held, oh...I get it.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$13.56
Change
0.000(0.00%)
Mkt cap ! $1.733B
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 8 $14.23
 

Sellers (Offers)

Price($) Vol. No.
$12.21 41 1
View Market Depth
Last trade - 09.56am 09/09/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.